- Home
- WYY vs DARE Comparison
WYY vs DARE Comparison
Compare WYY & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- DARE
- Stock Information
- Founded
- WYY 1991
- DARE 2015
- Country
- WYY United States
- DARE United States
- Employees
- WYY N/A
- DARE N/A
- Industry
- WYY EDP Services
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- DARE Health Care
- Exchange
- WYY Nasdaq
- DARE Nasdaq
- Market Cap
- WYY 33.4M
- DARE 27.7M
- IPO Year
- WYY 1998
- DARE N/A
- Fundamental
- Price
- WYY $3.10
- DARE $2.82
- Analyst Decision
- WYY Strong Buy
- DARE Strong Buy
- Analyst Count
- WYY 1
- DARE 3
- Target Price
- WYY $7.00
- DARE $12.50
- AVG Volume (30 Days)
- WYY 126.4K
- DARE 33.9K
- Earning Date
- WYY 08-13-2025
- DARE 08-11-2025
- Dividend Yield
- WYY N/A
- DARE N/A
- EPS Growth
- WYY N/A
- DARE N/A
- EPS
- WYY N/A
- DARE N/A
- Revenue
- WYY $142,582,209.00
- DARE $25,909.00
- Revenue This Year
- WYY $10.84
- DARE $99,756.91
- Revenue Next Year
- WYY $12.37
- DARE $119.77
- P/E Ratio
- WYY N/A
- DARE N/A
- Revenue Growth
- WYY 24.03
- DARE N/A
- 52 Week Low
- WYY $2.19
- DARE $2.67
- 52 Week High
- WYY $6.25
- DARE $5.76
- Technical
- Relative Strength Index (RSI)
- WYY 40.97
- DARE 39.02
- Support Level
- WYY $3.01
- DARE $2.84
- Resistance Level
- WYY $3.41
- DARE $2.93
- Average True Range (ATR)
- WYY 0.27
- DARE 0.13
- MACD
- WYY -0.02
- DARE -0.03
- Stochastic Oscillator
- WYY 7.53
- DARE 13.21
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.